,,iv  #aai? ,,congress  #a/ ,session    
,h4 ,,res4 #hjf  ,,9 ,,! ,,h\se ,,(     
,,repres5tatives  ,octob] #ad1 #bjbe,mr4
 ,c>t] ( ,georgia 7= himself1 ,mr4      
,mill] ( ,ohio1 ,mr4 ,de,saulnier1 ,mr4 
,morelle1 & ,ms4 ,wass]man ,s*ultz7     
submitt$ ! foll[+ resolution2 :i* 0     
ref]r$ to ! ,committee on ,ov]sight &   
,gov]nm5t ,re=m  ,,resolution  ,support+
 ! recognition ( ,octob] #bjbe z        
,national ,brea/ ,canc] ,aw>5ess ,mon?4 
,:]eas ,octob] #bjbe is ,national ,brea/
 ,canc] ,aw>5ess ,mon?1 :i* is an annual
 obs]vance increas+ public aw>5ess (    
brea/ canc] & promot+ ef=ts to advance  
rese>* & f9d a cure2 ,:]eas1 despite    
significant advances1 #a case ( brea/   
canc] is /ill diagnos$ 9 ! ,unit$ ,/ates
 e #b m9utes2 ,:]eas1 9 ! ,unit$ ,/ates1
 m ?an #cai1jjj new cases ( brea/ canc] 
w be diagnos$ 9 #bjbe1 & ne>ly #db1jjj p
 w die ( ! disease2 ,:]eas1 ?r\gh       
rese>*1 advocacy1 & improv$ e>ly        
detection & treatm5t1 ! #e-ye> relative 
survival rate is n[ ov] #ii p]c5t =     

brea/ canc] diagnos$ at a localiz$ /age1
 b drops to #hg p]c5t = regional /age & 
#cb p]c5t = meta/atic disease2 ,:]eas ! 
j\rney = _m individuals is q diff]5t1 ) 
m ?an #afh1jjj wom5 & an unkn[n numb] ( 
m5 liv+ ) meta/atic brea/ canc]1 a      
deva/at+ /age ( brea/ canc] :i* occurs  
:5 canc] spreads beyond ! brea/ to o!r  
p>ts ( ! body1 includ+ ! bones1 lungs1  
liv]1 & bra92 ,:]eas1 curr5tly1 no cure 
exi/s = meta/atic brea/ canc]1 & _m ( ^?
 ) meta/atic brea/ canc] w cont9ue      
treatm5t ) ! goal ( ext5d+ ! be/ quality
 ( life possible2 ,:]eas ,black wom5 are
 (t5 diagnos$ ) brea/ canc] at lat]     
/ages :5 treatm5ts are limit$ & co/ly1 &
 ! prognosis is poor1 & mortality rates 
are ne>ly #ch p]c5t high] ?an ,:ite     
wom52 ,:]eas brea/ canc] is ! mo/ common
 canc] diagnos$ & ! lead+ cause ( canc] 
dea? 9 ,hispanic wom52 ,:]eas brea/     
canc] mortality has decl9$ 9 e racial & 
e?nic gr\p s9ce #aiij1 except = ,am]ican
 ,indian & ,alaska ,native wom51 among  
:om rates h rema9$ /able2 ,:]eas !re has

 be5 a conc]n+ rise 9 brea/ canc]       
diagnoses 9 "y wom5 7"u ! age ( #ej7 9  
rec5t ye>s2 ,:]eas1 brea/ canc] incid5ce
 9 ! ,unit$ ,/ates increas$ f #bjab to  
#bjba1 ) a /eep] increase among wom5    
y\ng] ?an #ej ye>s ?an 9 ^? #ej or old]2
 ,:]eas "y wom5 diagnos$ ) brea/ canc]  
(t5 face unique issues includ+ e>ly     
m5opause1 loss ( f]tility1 difficulty   
brea/fe$+1 ov]all high] /age ( brea/    
canc] at diagnosis1 & m2 ,:]eas ! m ?an 
#d1jjj1jjj brea/ canc] survivors1 ^?    
liv+ ) ! disease1 & ! p :o love !m c    
atte/ to ! urg5t ne$ = access to timely1
 af=dable heal? c>e1 includ+ scre5+1    
diagnosis1 & treatm5t1 & robu/ fund+ =  
canc] rese>*2 & ,:]eas policymak]s are  
urg$ to address ! issues impact+ ! brea/
 canc] community 9 ! ,unit$ ,/ates3 ,n[1
 !re=e1 be x ,t ! ,h\se (               
,repres5tatives supports ! recognition (
 ,national ,brea/ ,canc] ,aw>5ess ,mon?4